ROS Technologies, Inc. is working in the development of a blood test to predict sudden cardiac death risk,specifically to reduce sudden death risk in heart failure. The companyâs first product was a blood test that discriminates with high predictive power who will and will not need an implanted defibrillator to prevent abnormal heartbeats and subsequent sudden death
